9-(b-D-Arabinofuranosyl)hypoxanthine
CAS: 7013-16-3
Ref. 3D-NA03401
1g | 271,00 € | ||
2g | 447,00 € | ||
5g | 732,00 € | ||
10g | 1.276,00 € | ||
500mg | 180,00 € |
Información del producto
- Arabinofuranosyl-hypoxanthine
- 6H-Purin-6-one, 9-beta-D-arabinofuranosyl-1,9-dihydro-
- 6H-Purin-6-one, 9-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-1,9-dihydro-
- 9-(b-D-Arabinofuranosyl) hypoxanthine
- 9-(beta-D-Arabinofuranosyl)hypoxanthine
- 9-(beta-D-arabinofuranosyl)-3,9-dihydro-6H-purin-6-one
- 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purin-6-one
- 9-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-1,9-dihydro-6H-purin-6-one
- 9-β-<span class="text-smallcaps">D</span>-Arabinofuranosylhypoxanthine
- Ara-H
- Ver más sinónimos
- Arabinosylhypoxanthine
- Arainosine
- Hypoxanthine arabinoside
- Hypoxanthine, 9-beta-D-arabinofuranosyl-
- Hypoxanthine, 9-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-
- Hypoxanthine-9-Beta-D-Arabinofuranoside
- Nsc 405122
9-(b-D-Arabinofuranosyl)hypoxanthine is a glycosylated analogue of the incretin hormone glucagon-like peptide-1 (GLP-1). It has been shown to inhibit Streptococcus pyogenes and other bacteria. 9-(b-D-Arabinofuranosyl)hypoxanthine has also been shown to have inhibitory properties against zirconium oxide, pulmonary vasodilation, squamous cell carcinoma, and rate constant. This drug has not been studied in clinical trials for antiviral prophylaxis or arabinoside. The only known side effects are drug interactions with cyclin D2 and nitrate reductase.
Propiedades químicas
Consulta técnica sobre: 3D-NA03401 9-(b-D-Arabinofuranosyl)hypoxanthine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.